Association between genetically proxied PCSK9 inhibition and prostate cancer risk: A Mendelian randomisation study - Fang, SM; Yarmolinsky, J; Gill, DR; Bull, CG; Perks, C; Smith, GD; Gaunt, T; Richardson, T (PLOS MEDICINE, 2023)